Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations

J Clin Lipidol. 2016 Jul-Aug;10(4):944-952.e1. doi: 10.1016/j.jacl.2016.04.005. Epub 2016 Apr 21.

Abstract

Background: Homozygous familial hypercholesterolemia is a rare clinical phenotype with a variable expression, which is characterized by extremely elevated plasma low-density lipoprotein (LDL), tendon and skin xanthomas, and a progressive atherosclerosis. In 95% of patients, homozygous familial hypercholesterolemia is due to mutations in low-density lipoprotein receptor (LDLR) gene, which abolish (receptor-negative) or greatly reduce (receptor-defective) LDLR function.

Objective: The objective of the study was the molecular and phenotypic characterization of 4 siblings with severe hypercholesterolemia.

Methods: The major LDL-related genes (LDLR, APOB, PCSK9, ANGPTL3, APOE, and APOC3) were sequenced. LDLR messenger RNA, isolated from leukocytes, was reverse transcribed and sequenced.

Results: The index cases were 24-year-old identical twin sisters with long-standing tendon xanthomas and high low-density lipoprotein cholesterol (LDL-C ∼10 mmol/L) but no coronary heart disease. They were carriers of 2 LDLR mutations: (1) a previously reported mutation [p.(G335S)] inherited from the mother who had LDL-C level within normal range; (2) a novel 24 bp deletion in exon 8/intron 8 junction inherited from the hypercholesterolemic (LDL-C 6.1 mmol/L) father. The deletion allele encodes an messenger RNA with a partial deletion of exon 8, whose translation product has an in-frame deletion of 17 amino acids [p.(Glu380_Gly396del)]. Family screening revealed that the 2 siblings of the twin sisters were also compound heterozygotes but had much lower LDL-C levels (8.2 and 7.1 mmol/L). The sequence of potential modifying genes showed that the 2 siblings and the mother of the twin sisters were heterozygous for a rare missense variant of apoB [p.(S2429T)], which might have an LDL-lowering effect.

Conclusions: We report a rare event of 4 siblings found to be compound heterozygotes for 2 LDLR gene mutations but showing a different phenotype severity. The less severely affected siblings were carriers of a rare apoB missense variant.

Keywords: APOB gene; Homozygous familial hypercholesterolemia; In-frame deletion; LDL cholesterol; LDLR gene; Missense mutations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apolipoproteins B / genetics
  • Base Sequence
  • Female
  • Heterozygote*
  • Humans
  • Hyperlipoproteinemia Type II / blood
  • Hyperlipoproteinemia Type II / genetics*
  • Lipoproteins, HDL / blood
  • Lipoproteins, LDL / blood
  • Male
  • Mutation*
  • Mutation, Missense
  • Pedigree
  • Phenotype*
  • Receptors, LDL / genetics*
  • Siblings*
  • Young Adult

Substances

  • Apolipoproteins B
  • LDLR protein, human
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Receptors, LDL